What does GlycoMimetics Inc’s (NASDAQ:GLYC) abstract data for the American Society for Clinical Oncology (ASCO) bring to the table for acute myeloid leukemia …
Gilead Sciences, Inc. (NASDAQ:GILD) hepatitis C franchise will again be in the spotlight when the pharmaceutical giant reports first-quarter earnings, scheduled for May 2, after …
Array Biopharma Inc (NASDAQ:ARRY) shares are dipping almost 8% after the discouraging news broke that the biotech firm has decided to withdraw its …
Micron Technology, Inc. (NASDAQ:MU) shares were rising almost 5% yesterday after Goldman Sachs decided to get bullish on the chip giant.
La Jolla Pharmaceutical Company (NASDAQ:LJPC) investors are overwhelmingly excited today after the drug maker reported compelling results from a phase 3 trial of its hypotension …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares rose as much as 9% during Friday’s trading session, after the drug maker announced changes to its ongoing Ocaliva …
Array Biopharma Inc (NASDAQ:ARRY) shares were soaring 17% yesterday on back of a second fiscal quarter update that has given investors signs of …
Cowen analyst Phil Nadeau is weighing in on Gilead Sciences, Inc. (NASDAQ:GILD) after the rumor mill was churning with reports that the biotech …
Stemline Therapeutics Inc (NASDAQ:STML) was mentioned cautiously in an article by Adam Feuerstein of TheStreet. According to to the report, a patient died …
Cowen analyst Ritu Baral weighs in today on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), after the drug maker provided an update focusing on the ongoing launch of …
